Difference between revisions of "VIPoma history and symptoms"

Jump to: navigation, search
Line 7: Line 7:
 
==Symptoms==
 
==Symptoms==
 
Symptoms of VIPoma may include any of the following:<ref name="sss">VIPoma. U.S. National Library of Medicine. Accessed on October 23, 2015. https://www.nlm.nih.gov/medlineplus/ency/article/000228.htm </ref><ref name="pmid16357627" /><ref name="pmid17510774">{{cite journal| author=Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ| title=Pancreatic VIPomas: subject review and one institutional experience. | journal=J Gastrointest Surg | year= 2008 | volume= 12 | issue= 2 | pages= 382-93 | pmid=17510774 | doi=10.1007/s11605-007-0177-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17510774  }} </ref><ref name="pmid235829162" />
 
Symptoms of VIPoma may include any of the following:<ref name="sss">VIPoma. U.S. National Library of Medicine. Accessed on October 23, 2015. https://www.nlm.nih.gov/medlineplus/ency/article/000228.htm </ref><ref name="pmid16357627" /><ref name="pmid17510774">{{cite journal| author=Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ| title=Pancreatic VIPomas: subject review and one institutional experience. | journal=J Gastrointest Surg | year= 2008 | volume= 12 | issue= 2 | pages= 382-93 | pmid=17510774 | doi=10.1007/s11605-007-0177-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17510774  }} </ref><ref name="pmid235829162" />
*Watery [[diarrhea]] like cholera and volume ranges from 750ml to more than 3 liters. Secretory diarrhea persists even on fasting for 48hours and is odorless. The stool appears like dilute tea.<ref>Vasoactive Intestinal Peptide Tumor (VIPoma)
+
*Watery [[diarrhea]] like cholera and volume ranges from 750ml to more than 3 liters. Secretory diarrhea persists even on fasting for 48hours and is odorless. The stool appears like dilute tea in color.<ref>Vasoactive Intestinal Peptide Tumor (VIPoma)
 
Aaron Vinik, MD, PhD, FCP, MACP, FACE
 
Aaron Vinik, MD, PhD, FCP, MACP, FACE
 
Murray Waitzer Endowed Chair for Diabetes Research, Professor of Medicine/Pathology/Neurobiology, Director of Research and Neuroendocrine Unit, Division of Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA</ref>
 
Murray Waitzer Endowed Chair for Diabetes Research, Professor of Medicine/Pathology/Neurobiology, Director of Research and Neuroendocrine Unit, Division of Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA</ref>

Revision as of 20:59, 3 January 2018

VIPoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating VIPoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

VIPoma history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of VIPoma history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on VIPoma history and symptoms

CDC on VIPoma history and symptoms

VIPoma history and symptoms in the news

Blogs on VIPoma history and symptoms</small>

Directions to Hospitals Treating VIPoma

Risk calculators and risk factors for VIPoma history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]

Overview

The hallmark of VIPoma is watery diarrhea. A positive history of abdominal pain, weight loss, numbness, and weakness is suggestive of VIPoma.[1][2][3][4]

Symptoms

Symptoms of VIPoma may include any of the following:[1][2][3][4]

References

  1. 1.0 1.1 VIPoma. U.S. National Library of Medicine. Accessed on October 23, 2015. https://www.nlm.nih.gov/medlineplus/ency/article/000228.htm
  2. 2.0 2.1 Remme CA, de Groot GH, Schrijver G (2006). "Diagnosis and treatment of VIPoma in a female patient.". Eur J Gastroenterol Hepatol. 18 (1): 93–9. PMID 16357627. 
  3. 3.0 3.1 Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ (2008). "Pancreatic VIPomas: subject review and one institutional experience.". J Gastrointest Surg. 12 (2): 382–93. PMID 17510774. doi:10.1007/s11605-007-0177-0. 
  4. 4.0 4.1 Ito T, Igarashi H, Jensen RT (2012). "Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.". Best Pract Res Clin Gastroenterol. 26 (6): 737–53. PMC 3627221Freely accessible. PMID 23582916. doi:10.1016/j.bpg.2012.12.003. 
  5. Vasoactive Intestinal Peptide Tumor (VIPoma) Aaron Vinik, MD, PhD, FCP, MACP, FACE Murray Waitzer Endowed Chair for Diabetes Research, Professor of Medicine/Pathology/Neurobiology, Director of Research and Neuroendocrine Unit, Division of Endocrine and Metabolic Disorders, Eastern Virginia Medical School, Norfolk, VA

Linked-in.jpg